11C-MET
Showing 26 - 50 of >10,000
Dosimetry of [11C]CHDI-180R and [11C]CHDI-626.
Completed
- Huntington Disease
- [11C]CHDI-00485180-R
- [11C]CHDI-00485626
-
Leuven, BelgiumUZ Leuven
May 18, 2022
MDD Trial in Shanghai (Toludivenlafaxine HCl sustained-release tablets)
Recruiting
- Major Depressive Disorder
- Toludivenlafaxine hydrochloride sustained-release tablets
-
Shanghai, Shanghai, ChinaShanghai Mental Health Center
Jun 14, 2023
Carcinoma, Hepatocellular Trial in Darmstadt (Tepotinib)
Completed
- Carcinoma, Hepatocellular
-
Darmstadt, GermanyPlease contact the Merck KGaA Communication Center located in
Aug 22, 2022
Mild Cognitive Impairment Trial in Winston-Salem ([11C]Acetoacetate[18F]Fluorodeoxyglucose positron emission tomography scan)
Enrolling by invitation
- Mild Cognitive Impairment
- [11C]Acetoacetate[18F]Fluorodeoxyglucose positron emission tomography scan
-
Winston-Salem, North CarolinaWake Forest School of Medicine
Dec 22, 2022
Colorectal Cancer Metastatic, C-met Overexpression Trial in Rozzano (Tivantinib (ARQ197))
Completed
- Colorectal Cancer Metastatic
- C-met Overexpression
- Tivantinib (ARQ197)
-
Rozzano, Milano, ItalyIstituto Clinico Humanitas
Sep 8, 2022
Endometrial Cancer Recurrent Trial in Tainan (Crizotinib 250 MG)
Recruiting
- Endometrial Cancer Recurrent
- Crizotinib 250 MG
-
Tainan, TaiwanNational Cheng Kung University Hospital
Jun 6, 2022
Amyotrophic Lateral Sclerosis Trial in Baltimore ([11C]CPPC Injection)
Recruiting
- Amyotrophic Lateral Sclerosis
- [11C]CPPC Injection
-
Baltimore, MarylandJohns Hopkins Outpatient Center
Jul 11, 2022
Solid Tumor Trial in United States (TR1801-ADC)
Active, not recruiting
- Unspecified Adult Solid Tumor, Protocol Specific
- TR1801-ADC
-
Los Angeles, California
- +4 more
Oct 30, 2022
Brain Cancer Trial in New York (PET scan, C-Choline)
Completed
- Brain Cancer
- PET scan
- C-Choline
-
New York, New YorkMemorial Sloan Kettering Cancer Center
May 9, 2022
Lymphangioleiomyomatosis, Tuberous Sclerosis Complex Trial in Boston ([11C]acetate)
Recruiting
- Lymphangioleiomyomatosis
- Tuberous Sclerosis Complex
-
Boston, MassachusettsBrigham and Women's Hospital
Jul 20, 2022
Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (procedure, biological, drug)
Not yet recruiting
- Recurrent Lung Non-Small Cell Carcinoma
- Stage IV Lung Cancer AJCC v8
- Biospecimen Collection
- +5 more
- (no location specified)
Sep 7, 2023
Lung in Pulmonary Artery Hypertension (PAH)
Not yet recruiting
- Pulmonary Arterial Hypertension
- Healthy
- TSPO PET scan (11C-PBR28)
- (no location specified)
Feb 16, 2023
Patients With Solid Tumors, Either Refractory to Standard Therapy or for Which no Effective Standard Therapy is Available Trial
Completed
- Patients With Solid Tumors, Either Refractory to Standard Therapy or for Which no Effective Standard Therapy is Available
-
Houston, TexasM.D. Anderson Cancer Center
Aug 22, 2022
HIV Associated Neurocognitive Disorder, HIV Dementia, HIV Encephalitis Trial (SV2A PET, TSPO PET)
Not yet recruiting
- HIV Associated Neurocognitive Disorder
- +3 more
- SV2A PET
- TSPO PET
- (no location specified)
Oct 16, 2022
Alzheimer Trial in Lille, Paris, Rouen ([11C]-UCB-J, [18F]-DPA-714, [18F]-RO-948)
Not yet recruiting
- Alzheimer Disease
- [11C]-UCB-J
- +3 more
-
Lille, France
- +2 more
Jun 12, 2023
Aberrant Synaptic Plasticity in Cocaine Use Disorder: A
Recruiting
- Cocaine Use Disorder
- Healthy Controls
- 11C-UCB-J
-
New Haven, ConnecticutConnecticut Mental Health Center
Aug 10, 2022
CS1P1 PET Studies of Neuroinflammation in Parkinson Disease
Not yet recruiting
- Parkinson Disease
-
Saint Louis, MissouriWashington University School of Medicine
Oct 10, 2023
Mild Cognitive Impairment Trial in Philadelphia (11C-acetate)
Terminated
- Mild Cognitive Impairment
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Apr 11, 2022
Advanced Hepatocellular Carcinoma With c-MET Dysregulation Trial in Worldwide (INC280)
Active, not recruiting
- Advanced Hepatocellular Carcinoma With c-MET Dysregulation
-
Nanjing, Jiangsu, China
- +7 more
Jan 12, 2023
Recurrent Squamous Cell Lung Carcinoma, Stage IV Squamous Cell Lung Carcinoma AJCC V7 Trial in Houston (ABBV-399)
Completed
- Recurrent Squamous Cell Lung Carcinoma
- Stage IV Squamous Cell Lung Carcinoma AJCC V7
-
Houston, TexasM D Anderson Cancer Center
Sep 21, 2021
Healthy Participants Trial in London ([11C]-Lu AF88370)
Completed
- Healthy Participants
- [11C]-Lu AF88370
-
London, United KingdomInvicro
Jul 12, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San Francisco
Recruiting
- Castration-Resistant Prostate Carcinoma
- +4 more
- Computed Tomography
- +3 more
-
San Francisco, CaliforniaUniversity of California San Francisco
Dec 19, 2022
[18F]Florbetazine for Beta Amyloid PET Imaging in Alzheimer's
Recruiting
- Alzheimer's Disease
- [18F]Florbetazine ([18F]92)
- [11C]PIB
-
Beijing, ChinaDepartment of Nuclear Medicine, Peking Union Medical College Hop
Nov 19, 2023